Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 407

1.

Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11.

Schloot NC, Pham MN, Hawa MI, Pozzilli P, Scherbaum WA, Schott M, Kolb H, Hunter S, Schernthaner G, Thivolet C, Seissler J, Leslie RD; Action LADA Group.

Diabetes Care. 2016 Aug 29. pii: dc160293. [Epub ahead of print]

PMID:
27573939
2.

Long latency between GAD-antibody detection and development of limbic encephalitis--a case report.

Fauser S, Uttner I, Ariño H, Scherbaum WA, Saiz A, Lewerenz J.

BMC Neurol. 2015 Sep 30;15:177. doi: 10.1186/s12883-015-0435-9.

3.

[Therapy of diabetes mellitus in old age].

Scherbaum WA.

MMW Fortschr Med. 2015 Apr 30;157(8):39-42. doi: 10.1007/s15006-015-3030-5. Review. German. No abstract available.

PMID:
26012681
4.

11-Keto-β-Boswellic Acids Prevent Development of Autoimmune Reactions, Insulitis and Reduce Hyperglycemia During Induction of Multiple Low-Dose Streptozotocin (MLD-STZ) Diabetes in Mice.

Shehata AM, Quintanilla-Fend L, Bettio S, Jauch J, Scior T, Scherbaum WA, Ammon HP.

Horm Metab Res. 2015 Jun;47(6):463-9. doi: 10.1055/s-0035-1547293. Epub 2015 May 7.

PMID:
25951322
5.

Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents.

Home PD, Dain MP, Freemantle N, Kawamori R, Pfohl M, Brette S, Pilorget V, Scherbaum WA, Vespasiani G, Vincent M, Balkau B.

Diabetes Res Clin Pract. 2015 May;108(2):350-9. doi: 10.1016/j.diabres.2015.01.030. Epub 2015 Jan 23.

6.

[Treatment of coma in diabetic ketoacidosis. Author reply].

Scherbaum WA, Scherbaum CR.

Med Klin Intensivmed Notfmed. 2015 Feb;110(1):77-8. German. No abstract available.

PMID:
25823363
7.

BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children.

Lauria A, Barker A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M, Van der Schueren B, Mandrup-Poulsen T, Scherbaum WA, Weets I, Gorus FK, Wareham N, Leslie RD, Pozzilli P.

Eur J Endocrinol. 2015 Feb;172(2):107-13. doi: 10.1530/EJE-14-0522. Epub 2014 Nov 6.

8.

[Diabetes emergencies].

Scherbaum WA, Scherbaum CR.

Med Klin Intensivmed Notfmed. 2014 May;109(4):279-92; quiz 293-4. doi: 10.1007/s00063-013-0334-z. Review. German.

PMID:
24820043
9.

[Cardiovascular effects of a lifestyle intervention in type 2 diabetes. The Look AHEAD (Action for Health in Diabetes) study].

Scherbaum WA, Nitschmann S.

Internist (Berl). 2014 Jun;55(6):735-8. doi: 10.1007/s00108-014-3513-y. German. No abstract available.

PMID:
24817540
10.

Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.

Barker A, Lauria A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M, Van der Schueren B, Mandrup-Poulsen T, Scherbaum WA, Weets I, Gorus FK, Wareham N, Leslie RD, Pozzilli P.

Diabetes Obes Metab. 2014 Mar;16(3):262-7. doi: 10.1111/dom.12216. Epub 2013 Oct 29.

PMID:
24118704
11.

[Bariatric surgery and diabetes mellitus: pioneering studies from 2012 and consequences for treatment strategies].

Scherbaum WA, Nitschmann S.

Internist (Berl). 2013 May;54(5):639-44. doi: 10.1007/s00108-013-3274-z. German. No abstract available.

PMID:
23568061
12.

Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.

Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Beck-Neilsen H, Tuomilehto J, Sarti C, Thivolet C, Hadden D, Hunter S, Schernthaner G, Scherbaum WA, Williams R, Brophy S, Pozzilli P, Leslie RD; Action LADA consortium.

Diabetes Care. 2013 Apr;36(4):908-13. doi: 10.2337/dc12-0931. Epub 2012 Dec 17. Erratum in: Diabetes Care. 2014 May;37(5):1494.

13.

Control of CYP11B2/CYP11B1 expression ratio and consequences for the zonation of the adrenal cortex.

Dringenberg T, Schwitalla M, Haase M, Scherbaum WA, Willenberg HS.

Horm Metab Res. 2013 Feb;45(2):81-5. doi: 10.1055/s-0032-1331210. Epub 2012 Dec 12.

PMID:
23235923
14.

Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study.

Soedamah-Muthu SS, Chaturvedi N, Fuller JH, Toeller M; EURODIAB Prospective Complications Study Group.

Eur J Nutr. 2013 Oct;52(7):1701-10. doi: 10.1007/s00394-012-0473-7. Epub 2012 Dec 7.

PMID:
23224030
15.

False positives on both dexamethasone testing and urinary free cortisol in women on oral contraception: dose-response effects.

Paschali M, Willenberg HS, Fritzen R, Schott M, Scherbaum WA, Schinner S.

Clin Endocrinol (Oxf). 2013 Sep;79(3):443-4. doi: 10.1111/cen.12098. Epub 2013 Apr 19. No abstract available.

PMID:
23140463
16.

Localization and regulation of pancreatic selenoprotein P.

Steinbrenner H, Hotze AL, Speckmann B, Pinto A, Sies H, Schott M, Ehlers M, Scherbaum WA, Schinner S.

J Mol Endocrinol. 2012 Dec 31;50(1):31-42. doi: 10.1530/JME-12-0105. Print 2013 Feb.

17.

Griseofulvin inhibits the growth of adrenocortical cancer cells in vitro.

Bramann EL, Willenberg HS, Hildebrandt B, Müller-Mattheis V, Schott M, Scherbaum WA, Haase M.

Horm Metab Res. 2013 Apr;45(4):297-300. doi: 10.1055/s-0032-1327642. Epub 2012 Oct 30.

PMID:
23111828
18.

HLA-A2 phenotype may be protective against Graves' disease but not against Hashimoto's thyroiditis in Caucasians.

Bernecker C, Ostapczuk M, Vordenbäumen S, Ehlers M, Thiel A, Schinner S, Willenberg H, Scherbaum WA, Schott M.

Horm Metab Res. 2013 Jan;45(1):74-7. doi: 10.1055/s-0032-1323704. Epub 2012 Sep 12.

PMID:
22972181
19.

Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: the EURODIAB study.

van Bussel BC, Soedamah-Muthu SS, Henry RM, Schalkwijk CG, Ferreira I, Chaturvedi N, Toeller M, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.

Nutr Metab Cardiovasc Dis. 2013 Aug;23(8):758-64. doi: 10.1016/j.numecd.2012.04.005. Epub 2012 Jul 12.

PMID:
22795869
20.

Immunoregulatory natural killer cells suppress autoimmunity by down-regulating antigen-specific CD8+ T cells in mice.

Ehlers M, Papewalis C, Stenzel W, Jacobs B, Meyer KL, Deenen R, Willenberg HS, Schinner S, Thiel A, Scherbaum WA, Ullrich E, Zitvogel L, Schott M.

Endocrinology. 2012 Sep;153(9):4367-79. doi: 10.1210/en.2012-1247. Epub 2012 Jun 25.

PMID:
22733969
Items per page

Supplemental Content

Loading ...
Write to the Help Desk